Trimetazidine Alleviates Postresuscitation Myocardial Dysfunction and Improves 96‐Hour Survival in a Ventricular Fibrillation Rat Model

BACKGROUND: Myocardial dysfunction is a critical cause of post‐cardiac arrest hemodynamic instability and circulatory failure that may lead to early mortality after resuscitation. Trimetazidine is a metabolic agent that has been demonstrated to provide protective effects in myocardial ischemia. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingru, Qi, Yuantong, Wang, Jianjie, Dai, Chenxi, Chen, Bihua, Li, Yongqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075307/
https://www.ncbi.nlm.nih.gov/pubmed/35261264
http://dx.doi.org/10.1161/JAHA.121.023378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075307/
https://www.ncbi.nlm.nih.gov/pubmed/35261264
http://dx.doi.org/10.1161/JAHA.121.023378

Ejemplares similares